Pilot study of H<sub>2</sub> therapy in Parkinson's disease: A randomized double‐blind placebo‐controlled trial
Asako Yoritaka(Juntendo University), Nobutaka Hattori(RIKEN Center for Brain Science), Toshiki Nakahara(Juntendo University), Shigeo Ohta(Nippon Medical School), Masaaki Hirayama(Chubu University), Masashi Takanashi(Juntendo University)
Cited by 158
Related Papers
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
|Nature Genetics|2000|2k
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
|The Journal of Cell Biology|2010|1.9k